2016
DOI: 10.1099/jgv.0.000500
|View full text |Cite
|
Sign up to set email alerts
|

A molecular modelling approach to understand the effect of co-evolutionary mutations (V344M, I354L) identified in the PB2 subunit of influenza A 2009 pandemic H1N1 virus on m7GTP ligand binding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 58 publications
(56 reference statements)
0
3
0
Order By: Relevance
“…The largest of the polymerases, PB2, possessed nine fixed variants: R54K, M66I, D195N, R293K, R299K, V344M, I354L, S453T, and V731I. Of these, I354 and S453 lie in the cap-binding domain that is essential for the cap-snatching mechanism during the viral RNA transcription process [50] (Figure 1). Most of the sporadically detected variants in polymerases clustered in one patient suffering from enhanced respiratory symptoms including peribronchial markings and mucus accumulation in lungs.…”
Section: Mutation Analysismentioning
confidence: 99%
“…The largest of the polymerases, PB2, possessed nine fixed variants: R54K, M66I, D195N, R293K, R299K, V344M, I354L, S453T, and V731I. Of these, I354 and S453 lie in the cap-binding domain that is essential for the cap-snatching mechanism during the viral RNA transcription process [50] (Figure 1). Most of the sporadically detected variants in polymerases clustered in one patient suffering from enhanced respiratory symptoms including peribronchial markings and mucus accumulation in lungs.…”
Section: Mutation Analysismentioning
confidence: 99%
“…Given the essential and multi-functional roles of influenza A proteins, there are many options when it comes to selecting an antiviral drug target(s), with almost all major proteins having been the subject of extensive investigation. Furthermore, molecular dynamics, docking and virtual screening protocols have also been combined as integrative strategies to identify influenza A inhibitors, and identify binding pockets [25][26][27][28] as shown in figure 2. These methods have also been applied after initial experimental work to analyse molecular interactions.…”
Section: Discovery Of Influenza a Inhibitors And Drug Targetsmentioning
confidence: 99%
“…The NA of H5N1 and pH1N1 with H274Y mutation significantly weakened the binding affinity for the anti-viral drug oseltamivir, which resulted from the loss of H-bond interactions between the oseltamivir and two residues of NA (178W and 152R) 14 . Moreover, co-mutations V344M and I354L in the PB2 subunit of pH1N1 enhanced binding affinity by creating additional H-bond contacts between PB2 cap binding domain and the pre-mRNA cap analogue m7GTP 15 . However, these researches, as stated, were specific to a few influenza subtypes and only covered a few of proteins.…”
Section: Introductionmentioning
confidence: 99%